Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study

BackgroundBoth light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis are types of cardiac amyloidosis (CA) that require accurate prognostic stratification to plan therapeutic strategies and follow-ups. Cardiac biomarkers, e.g., N-terminal pro-B-type natriuretic peptide (NT-proBNP) and hi...

Full description

Bibliographic Details
Published in:Frontiers in Cardiovascular Medicine
Main Authors: Martin Nicol, Giuseppe Vergaro, Thibaud Damy, Mounira Kharoubi, Mathilde Baudet, Elena Sofia Canuti, Alberto Aimo, Vincenzo Castiglione, Michele Emdin, Bruno Royer, Stephanie Harel, Alain Cohen-Solal, Bertrand Arnulf, Damien Logeart
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Subjects:
cardiac amyloidosis
AL
TTR
sST2
biomarker
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1179968/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1179968/full

Similar Items